Radboud Institute for Health Sciences, Department Intensive Care Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Department of Intensive Care Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Intensive Care Med. 2022 Mar;48(3):322-331. doi: 10.1007/s00134-021-06615-8. Epub 2022 Feb 1.
PURPOSE: Long-term mental outcomes in family members of coronavirus disease 2019 (COVID-19) intensive care unit (ICU) survivors are unknown. Therefore, we assessed the prevalence of mental health symptoms, including associated risk factors, and quality of life (QoL) in family members of COVID-19 ICU survivors 3 and 12 months post-ICU. METHODS: A prospective multicentre cohort study in ICUs of ten Dutch hospitals, including adult family members of COVID-19 ICU survivors admitted between March 1, and July 1, 2020. Symptom prevalence rates of anxiety, depression (Hospital Anxiety and Depression Scale) and Post-Traumatic Stress Disorder (Impact of Event Scale-6), and QoL (Short Form-12) before ICU admission (baseline), and after 3 and 12 months were measured. Additionally, associations between family and patient characteristics and mental health symptoms were calculated. RESULTS: A total of 166 out of 197 (84.3%) included family members completed the 12-month follow-up of whom 46.1% and 38.3% had mental health symptoms 3 and 12 months post-ICU, respectively; both higher compared to baseline (22.4%) (p < 0.001). The mental component summary score of the SF-12 was lower at 12-month follow-up compared with baseline [mean difference mental component score: - 5.5 (95% confidence interval (CI) - 7.4 to - 3.6)]. Furthermore, 27.9% experienced work-related problems. Symptoms of anxiety (odds ratio (OR) 9.23; 95% CI 2.296-37.24; p = 0.002) and depression (OR 5.96; 95% CI 1.29-27.42; p = 0.02) prior to ICU admission were identified as risk factors for mental health symptoms after 12 months. CONCLUSION: A considerable proportion of family members of COVID-19 survivors reported mental health symptoms 3 and 12 months after ICU admission, disrupting QoL and creating work-related problems.
目的:新冠肺炎(COVID-19)重症监护病房(ICU)幸存者家属的长期心理健康结果尚不清楚。因此,我们评估了 COVID-19 ICU 幸存者家属在 ICU 后 3 个月和 12 个月时心理健康症状的患病率,包括相关的危险因素和生活质量(QoL)。
方法:这是一项在荷兰 10 家医院 ICU 中进行的前瞻性多中心队列研究,包括 COVID-19 ICU 幸存者的成年家属,这些家属于 2020 年 3 月 1 日至 7 月 1 日期间入住 ICU。在 ICU 入院前(基线)、3 个月和 12 个月时,测量焦虑、抑郁(医院焦虑和抑郁量表)和创伤后应激障碍(事件影响量表-6)的症状患病率以及 QoL(简短形式-12)。此外,还计算了家庭和患者特征与心理健康症状之间的关联。
结果:在 197 名被纳入的家属中,共有 166 名(84.3%)完成了 12 个月的随访,其中 46.1%和 38.3%的人在 ICU 后 3 个月和 12 个月时有心理健康症状,均高于基线时(22.4%)(p<0.001)。SF-12 的心理成分综合评分在 12 个月随访时低于基线[心理成分评分平均差异:-5.5(95%置信区间(CI)-7.4 至-3.6)]。此外,27.9%的人出现与工作相关的问题。ICU 入院前出现焦虑症状(优势比(OR)9.23;95%置信区间(CI)2.296-37.24;p=0.002)和抑郁症状(OR 5.96;95% CI 1.29-27.42;p=0.02)被确定为 12 个月后心理健康症状的危险因素。
结论:相当一部分 COVID-19 幸存者的家属在 ICU 后 3 个月和 12 个月时报告出现心理健康症状,这会扰乱生活质量并导致与工作相关的问题。
Intensive Care Med. 2018-10-23
Crit Care Med. 2016-10
Osong Public Health Res Perspect. 2024-2
Intensive Care Med. 2021-10
BMJ. 2021-7-26
Lancet Respir Med. 2021-8
BMC Fam Pract. 2021-6-29